Rick E. Winningham - 23 Jun 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
23 Jun 2025
Net transactions value
$0
Form type
4
Filing time
25 Jun 2025, 18:06:00 UTC
Previous filing
17 Jun 2025
Next filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Winningham Rick E CHIEF EXECUTIVE OFFICER, Director C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO /s/ Brett A. Grimaud, Attorney-in-Fact 25 Jun 2025 0001302443

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Gift $0 -20,000 -1.1% $0.000000 1,733,180 23 Jun 2025 Direct F1
holding TBPH Ordinary Shares 13,500 23 Jun 2025 As Custodian
holding TBPH Ordinary Shares 92,567 23 Jun 2025 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona Fide Gift. No compensation was given to the donor for the gifting of shares.